For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

Uniphar is expanding its footprint with new facilities in the United States and elsewhere to better support pharma and medtech manufacturers.

The modular sterile filling system reportedly can deliver 500 to 50,000 units per batch specifically tailored for process development.

The platform enables direct, unbiased genome-wide identification and quantification of the exact position of double strand DNA breaks in edited cells.

A new approach that used CRISPR to engineer adipocytes and implant them in mice models of cancer reduced cancer progression.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

Researcher suggest findings could help understand what happens in the brain when fear response regulation is impaired.

AI-powered research on one of the largest eye studies to date has created the most detailed maps of the retina ever produced.

In a small human trial in SMA patients neurostimulation sessions improved motoneuron function, reduced fatigue, and improved leg muscle strength and walking.

CEO Serge Saxonov, PhD, says provider of single cell, spatial, and in situ instruments expects to see benefits from sales ...